Eisai's Leqembi Iqlik Gets Priority Review for Home Injection in Alzheimer's Treatment Eisai announces that the FDA has granted Priority Review for the subcutaneous form of Leqembi Iqlik, enabling at-home treatments for Alzheimer's.

Eisai's Leqembi Iqlik Gets Priority Review for Home Injection in Alzheimer's Treatment #USA #Stockholm #Eisai #Leqembi #IQLIK

LEQEMBI® IQLIK™ Autoinjector Recognized by TIME as a Top Invention of 2025 Eisai and Biogen's innovative LEQEMBI® IQLIK™ for Alzheimer's treatment has been named one of TIME's best inventions of 2025, revolutionizing patient care.

LEQEMBI® IQLIK™ Autoinjector Recognized by TIME as a Top Invention of 2025 #Japan #Tokyo #Leqembi #Alzheimer's #IQLIK